Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Drinking Excessive in Singapore
Total 0 results
Nothing found
Sponsors and Collaborators
Sociedad Española de Arteriosclerosis
Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
Brigham and Womens' Hospital, Center for Surgery and Public Health
The Depressive and Bipolar Disorder Alternative Treatment Foundation
Paul W. Read, MD
wenbinlu
Sonogenix
Remedy Institute
Resurge Therapeutics Inc.
Carlos III Health Institute
Zhijun Sun
Laboratoires Iprad-Vegebom
NATURAmedicatrix Sàrl
Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
Health Holding Company, Hail Health Cluster, Saudi Arabia
Australian Childhood Foundation
Prader-Willi Syndrome Association of Australia
Kettering Foundation
Epicentre, Paris, France.
Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
View Full List
Medical Conditions
Ankle Trauma
Intervention Studies
Lymphoblastic Lymphoma
Stroke Recrudescence
Apneic; Oxygenation
Malignant Tumor of Extrahepatic Bile Duct
Cell Senescence
Pregnancy; Accident
Mycobacterium Avium Complex Infections
Adherence to In-Office Glaucoma Evaluation Appointment
Psychoactive Substance Use
Hernia,Ventral
Marginal Zone B-cell Lymphoma
Escape Room Games and Role Playing Gamification
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Stage IIIB Esophageal Adenocarcinoma
Stage III Childhood Anaplastic Large Cell Lymphoma
Refractory B-Lineage Lymphoma
Spinocerebellar Ataxia Genotype Type 3
Neurobehavioral Manifestation
View Full List
Drug Interventions
Omeprazole 40 mg
Gadoteridol (ProHance)
ART-123
Colecalciferol D3 (Vigantol Oil)
Optiva artificial tear by Allergan
Fostamatinib
Triple therapy
Irinotecan
FRSW107
Oral Aztreonam
Low molecular weight Heparin as standard of care treatment
Epalrestat
SBI-087
Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
300 mg of caffeine citrate infusion
Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
Fenofibric acid 135mg
Everolimus
LINjeta U-100 Insulin
Lansoprazole 15mg QD
View Full List
CROs by country
Contract Research Organizations in Belgium
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Gabon
Contract Research Organizations in Greece
Contract Research Organizations in Italy
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Lebanon
Contract Research Organizations in New Zealand
Contract Research Organizations in Norway
Contract Research Organizations in Slovakia
Contract Research Organizations in Uganda
Contract Research Organizations in Ukraine
Contract Research Organizations in United States
CRO list by country
CROs in Austria
IST Austria
FAVORGEN Biotech Corporation
Eppendorf
BIOCRATES Life Sciences
JOANNEUM RESEARCH – HEALTH Institute for Biomedicine and Health Sciences
F-star
Synteract
Globopharm
Envigo
E&E CRO Consulting
All CROs in Austria
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe